DV1 is a selective antagonist of the CXC chemokine receptor 4 (CXCR4). It demonstrates antiviral activity by blocking HIV-1 entry via the CXCR4 co-receptor. Additionally, DV1 is stable in rat plasma and exhibits favorable pharmacokinetic properties in rat models.
Formula:
C108H170N34O26S2
Target:
HIV Protease|||CXCR
* VAT and and shipping costs not included. Errors and price changes excepted
